Madrigal Pharmaceuticals, Inc. MDGL Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s interest income?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported interest income of $8.24M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s interest income decreased by 12.0% year-over-year, from $9.37M to $8.24M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s interest income has grown at a 218.5% compound annual growth rate (CAGR), from $363K to $37.36M.
- What does interest income mean?
- The money earned from interest on cash holdings and investments.
- How do you interpret interest income?
- An increase suggests higher cash balances or a more favorable interest rate environment, while a decrease reflects lower cash reserves or lower market interest rates.
- How does interest income compare across companies?
- Interest income is highly dependent on the company's cash position and prevailing market interest rates, making it comparable across the industry.